What does cardiopulmonary — foreign currency adjustments mean?

Reflects the impact of exchange rate fluctuations on the cardiopulmonary segment's financial results when translating international operations into the reporting currency. This metric helps isolate the effect of currency volatility from underlying operational performance.

LivaNova LIVN Cardiopulmonary — Foreign currency adjustments

Other segment segments

Neuromodulation

$0—

Similar metrics at other companies

BSXCardiovascular — Impact of foreign currency fluctuations and purchase price and other adjustments

-$14M-147%

MDTCardiovascular — Currency translation and other

$10M-88.6%

GNTXOther — Foreign currency adjustment

-$52.83K—

FISCorporate and Other — Foreign currency adjustments

$0—

AFLCritical care — Foreign currency translation and other

$0—

LDOSHealth — Foreign currency translation adjustments

$0—

Other financials

Income statement

See full

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

See full

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

See full

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

See full

Market cap$4.32B+62.8%

Profitability

See full

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

See full

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's cardiopulmonary — foreign currency adjustments.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LivaNova's cardiopulmonary — foreign currency adjustments?: LivaNova (LIVN) reported cardiopulmonary — foreign currency adjustments of -$7.25M in Q1 2026.
How has LivaNova's cardiopulmonary — foreign currency adjustments changed year-over-year?: LivaNova's cardiopulmonary — foreign currency adjustments decreased by 160.9% year-over-year, from $11.91M to -$7.25M.
What does cardiopulmonary — foreign currency adjustments mean?: Reflects the impact of exchange rate fluctuations on the cardiopulmonary segment's financial results when translating international operations into the reporting currency. This metric helps isolate the effect of currency volatility from underlying operational performance.